Return
Tumour progression shows decrease in PD-L1 expression in matched metastases/primary uveal melanomas
DOI:10.1111/aos.17559.png)
Abstract
En 中文
Immune checkpoint inhibitors (ICI) have revolutionised the treatment of several malignancies. However, the results of ICI therapy remain unsatisfactory in metastatic uveal melanoma (UM). We analysed the expression of PD1, PD-L1, T-cell and macrophage markers in a set of matched primary and metastatic UM in an attempt to better understand the low effectiveness of ICI in metastatic UM.
Keywords:
immune checkpoint
metastases
microenvironment
uveal melanoma
Journal
IF:
2.8
Papers:
1.1W
Citations:
1.1W
Organization
Cited Papers
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
NATURE COMMUNICATIONS
IF15.7

